Royalty Pharma plc
NASDAQ:RPRX
Overview | Financials
Company Name | Royalty Pharma plc |
Symbol | RPRX |
Currency | USD |
Price | 26 |
Market Cap | 11,551,852,000 |
Dividend Yield | 2.89% |
52-week-range | 25.2 - 31.655 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Pablo Gerardo Legorreta |
Website | https://www.royaltypharma.com |
An error occurred while fetching data.
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD